Geron Corp (GERN) stock
GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.00+0.06 (+6.17%)
Close on Nov 17, 2026Market cap $642.47MP/E –Yield –
Geron operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Geron's operating cash flow for the twelve months ending Jun 30, 2026 was -$114.38M. For fiscal 2025 it was -$111.04M. The highest annual figure on record is $9.35M in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$111.04M | – |
| FY2024 | Dec 31, 2024 | -$218.62M | – |
| FY2023 | Dec 31, 2023 | -$167.74M | – |
| FY2022 | Dec 31, 2022 | -$127.38M | – |
| FY2021 | Dec 31, 2021 | -$95.56M | – |
| FY2020 | Dec 31, 2020 | -$66.65M | – |
| FY2019 | Dec 31, 2019 | -$43.83M | – |
| FY2018 | Dec 31, 2018 | -$21.01M | – |
| FY2017 | Dec 31, 2017 | -$20.56M | – |
| FY2016 | Dec 31, 2016 | -$18.37M | – |
| FY2015 | Dec 31, 2015 | -$24.20M | -358.8% |
| FY2014 | Dec 31, 2014 | $9.35M | – |
| FY2013 | Dec 31, 2013 | -$36.68M | – |
| FY2012 | Dec 31, 2012 | -$55.15M | – |
| FY2011 | Dec 31, 2011 | -$62.39M | – |
| FY2010 | Dec 31, 2010 | -$44.29M | – |
| FY2009 | Dec 31, 2009 | -$43.37M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$15.83M | – |
| Q1 FY2026 | Mar 31, 2026 | -$62.91M | – |
| Q4 FY2025 | Dec 31, 2025 | -$22.07M | – |
| Q3 FY2025 | Sep 30, 2025 | -$13.58M | – |
| Q2 FY2025 | Jun 30, 2025 | -$27.42M | – |
| Q1 FY2025 | Mar 31, 2025 | -$47.98M | – |
| Q4 FY2024 | Dec 31, 2024 | -$43.95M | – |
| Q3 FY2024 | Sep 30, 2024 | -$58.94M | – |
| Q2 FY2024 | Jun 30, 2024 | -$53.48M | – |
| Q1 FY2024 | Mar 31, 2024 | -$62.25M | – |
| Q4 FY2023 | Dec 31, 2023 | -$40.94M | – |
| Q3 FY2023 | Sep 30, 2023 | -$50.84M | – |
| Q2 FY2023 | Jun 30, 2023 | -$29.60M | – |
| Q1 FY2023 | Mar 31, 2023 | -$46.37M | – |
| Q4 FY2022 | Dec 31, 2022 | -$35.18M | – |
| Q3 FY2022 | Sep 30, 2022 | -$29.58M | – |
| Q2 FY2022 | Jun 30, 2022 | -$28.64M | – |
| Q1 FY2022 | Mar 31, 2022 | -$33.97M | – |
| Q4 FY2021 | Dec 31, 2021 | -$22.17M | – |
| Q3 FY2021 | Sep 30, 2021 | -$22.84M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.81M | – |
| Q1 FY2021 | Mar 31, 2021 | -$32.73M | – |
| Q4 FY2020 | Dec 31, 2020 | -$12.61M | – |
| Q3 FY2020 | Sep 30, 2020 | -$15.45M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.40M | – |
| Q1 FY2020 | Mar 31, 2020 | -$26.19M | – |
| Q4 FY2019 | Dec 31, 2019 | -$10.37M | – |
| Q3 FY2019 | Sep 30, 2019 | -$11.98M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.75M | – |
| Q1 FY2019 | Mar 31, 2019 | -$12.74M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.01M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.14M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.50M | – |
| Q1 FY2018 | Mar 31, 2018 | -$7.37M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.39M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.42M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.44M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.31M | – |
| Q4 FY2016 | Dec 31, 2016 | -$602.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.55M | – |
See a number that looks wrong?